Acetaminophen down-regulates interleukin-1β-induced nuclear factor-κB nuclear translocation in a human astrocytic cell line

Francesca Mancini, Carla Landolfi, Marta Muzio, Luciano Aquilini, Lucia Soldo, Isabella Coletta, Angelo Guglielmotti, Alberto Mantovani, Mario Pinza, Claudio Milanese

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In previous studies performed to elucidate acetaminophen mechanism of action, we demonstrated that acetaminophen inhibits prostaglandin E2 production by interleukin (IL)-1β-stimulated T98G human astrocytic cells, without affecting cyclooxygenase-2 enzymatic activity. As this result suggests an effect at transcriptional level, we examined whether the drug interferes with the activation of nuclear factor (NF)-κB and STAT3 transcription factors and with SAPK signal transducing factor. Western blot analysis of IκBα protein in the cytoplasm of IL-1β-stimulated T98G cells and electrophoretic mobility shift assay (EMSA) on corresponding nuclear extracts indicate that acetaminophen (10-1000 μM) dose-dependently inhibits both IκBα degradation and NF-κB nuclear translocation. In the same cell type neither IL-1β-dependent SAPK activation nor IL-6-induced STAT3 phosphorylation is affected by the drug. These data indicate that therapeutic concentrations of acetaminophen induce an inhibition of IL-1β-dependent NF-κB nuclear translocation. The selectivity of this effect suggests the existence of an acetaminophen specific activity at transcriptional level that may be one of the mechanisms through which the drug exerts its pharmacological effects.

Original languageEnglish
Pages (from-to)79-82
Number of pages4
JournalNeuroscience Letters
Volume353
Issue number2
DOIs
Publication statusPublished - Dec 19 2003

Fingerprint

Acetaminophen
Interleukin-1
Down-Regulation
Cell Line
Pharmaceutical Preparations
STAT3 Transcription Factor
Electrophoretic Mobility Shift Assay
Cyclooxygenase 2
Dinoprostone
Interleukin-6
Cytoplasm
Western Blotting
Phosphorylation
Pharmacology
Proteins
Therapeutics

Keywords

  • Acetaminophen
  • Interleukin-1β
  • NF-κB
  • Nuclear translocation
  • Signal transcription
  • Signal transduction

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Acetaminophen down-regulates interleukin-1β-induced nuclear factor-κB nuclear translocation in a human astrocytic cell line. / Mancini, Francesca; Landolfi, Carla; Muzio, Marta; Aquilini, Luciano; Soldo, Lucia; Coletta, Isabella; Guglielmotti, Angelo; Mantovani, Alberto; Pinza, Mario; Milanese, Claudio.

In: Neuroscience Letters, Vol. 353, No. 2, 19.12.2003, p. 79-82.

Research output: Contribution to journalArticle

Mancini, Francesca ; Landolfi, Carla ; Muzio, Marta ; Aquilini, Luciano ; Soldo, Lucia ; Coletta, Isabella ; Guglielmotti, Angelo ; Mantovani, Alberto ; Pinza, Mario ; Milanese, Claudio. / Acetaminophen down-regulates interleukin-1β-induced nuclear factor-κB nuclear translocation in a human astrocytic cell line. In: Neuroscience Letters. 2003 ; Vol. 353, No. 2. pp. 79-82.
@article{b35431f991fd4a209e1a6e980f5fb924,
title = "Acetaminophen down-regulates interleukin-1β-induced nuclear factor-κB nuclear translocation in a human astrocytic cell line",
abstract = "In previous studies performed to elucidate acetaminophen mechanism of action, we demonstrated that acetaminophen inhibits prostaglandin E2 production by interleukin (IL)-1β-stimulated T98G human astrocytic cells, without affecting cyclooxygenase-2 enzymatic activity. As this result suggests an effect at transcriptional level, we examined whether the drug interferes with the activation of nuclear factor (NF)-κB and STAT3 transcription factors and with SAPK signal transducing factor. Western blot analysis of IκBα protein in the cytoplasm of IL-1β-stimulated T98G cells and electrophoretic mobility shift assay (EMSA) on corresponding nuclear extracts indicate that acetaminophen (10-1000 μM) dose-dependently inhibits both IκBα degradation and NF-κB nuclear translocation. In the same cell type neither IL-1β-dependent SAPK activation nor IL-6-induced STAT3 phosphorylation is affected by the drug. These data indicate that therapeutic concentrations of acetaminophen induce an inhibition of IL-1β-dependent NF-κB nuclear translocation. The selectivity of this effect suggests the existence of an acetaminophen specific activity at transcriptional level that may be one of the mechanisms through which the drug exerts its pharmacological effects.",
keywords = "Acetaminophen, Interleukin-1β, NF-κB, Nuclear translocation, Signal transcription, Signal transduction",
author = "Francesca Mancini and Carla Landolfi and Marta Muzio and Luciano Aquilini and Lucia Soldo and Isabella Coletta and Angelo Guglielmotti and Alberto Mantovani and Mario Pinza and Claudio Milanese",
year = "2003",
month = "12",
day = "19",
doi = "10.1016/j.neulet.2003.08.074",
language = "English",
volume = "353",
pages = "79--82",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Acetaminophen down-regulates interleukin-1β-induced nuclear factor-κB nuclear translocation in a human astrocytic cell line

AU - Mancini, Francesca

AU - Landolfi, Carla

AU - Muzio, Marta

AU - Aquilini, Luciano

AU - Soldo, Lucia

AU - Coletta, Isabella

AU - Guglielmotti, Angelo

AU - Mantovani, Alberto

AU - Pinza, Mario

AU - Milanese, Claudio

PY - 2003/12/19

Y1 - 2003/12/19

N2 - In previous studies performed to elucidate acetaminophen mechanism of action, we demonstrated that acetaminophen inhibits prostaglandin E2 production by interleukin (IL)-1β-stimulated T98G human astrocytic cells, without affecting cyclooxygenase-2 enzymatic activity. As this result suggests an effect at transcriptional level, we examined whether the drug interferes with the activation of nuclear factor (NF)-κB and STAT3 transcription factors and with SAPK signal transducing factor. Western blot analysis of IκBα protein in the cytoplasm of IL-1β-stimulated T98G cells and electrophoretic mobility shift assay (EMSA) on corresponding nuclear extracts indicate that acetaminophen (10-1000 μM) dose-dependently inhibits both IκBα degradation and NF-κB nuclear translocation. In the same cell type neither IL-1β-dependent SAPK activation nor IL-6-induced STAT3 phosphorylation is affected by the drug. These data indicate that therapeutic concentrations of acetaminophen induce an inhibition of IL-1β-dependent NF-κB nuclear translocation. The selectivity of this effect suggests the existence of an acetaminophen specific activity at transcriptional level that may be one of the mechanisms through which the drug exerts its pharmacological effects.

AB - In previous studies performed to elucidate acetaminophen mechanism of action, we demonstrated that acetaminophen inhibits prostaglandin E2 production by interleukin (IL)-1β-stimulated T98G human astrocytic cells, without affecting cyclooxygenase-2 enzymatic activity. As this result suggests an effect at transcriptional level, we examined whether the drug interferes with the activation of nuclear factor (NF)-κB and STAT3 transcription factors and with SAPK signal transducing factor. Western blot analysis of IκBα protein in the cytoplasm of IL-1β-stimulated T98G cells and electrophoretic mobility shift assay (EMSA) on corresponding nuclear extracts indicate that acetaminophen (10-1000 μM) dose-dependently inhibits both IκBα degradation and NF-κB nuclear translocation. In the same cell type neither IL-1β-dependent SAPK activation nor IL-6-induced STAT3 phosphorylation is affected by the drug. These data indicate that therapeutic concentrations of acetaminophen induce an inhibition of IL-1β-dependent NF-κB nuclear translocation. The selectivity of this effect suggests the existence of an acetaminophen specific activity at transcriptional level that may be one of the mechanisms through which the drug exerts its pharmacological effects.

KW - Acetaminophen

KW - Interleukin-1β

KW - NF-κB

KW - Nuclear translocation

KW - Signal transcription

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=10744231277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744231277&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2003.08.074

DO - 10.1016/j.neulet.2003.08.074

M3 - Article

C2 - 14664905

AN - SCOPUS:10744231277

VL - 353

SP - 79

EP - 82

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -